Researchers have been awarded a $3 million Breakthrough prize for their work on measuring the magnetic properties of the muon particle, a key component in the standard model of particle physics. Despite the precision of their findings, discrepancies remain between two methods used to predict these properties, leaving some mysteries unsolved. The prize was shared among hundreds of collaborators from Fermilab, CERN, and Brookhaven National Laboratory. Additionally, three life-science prizes were awarded for advances in gene therapies, including the development of Luxturna, a treatment for an inherited retinal disease. This therapy, created by Jean Bennett, Albert Maguire, and Katherine High, has shown significant improvements in patients’ vision. High plans to donate her prize money to support high school students.
QUESTION: How might advancements in gene therapy impact the future of medical treatments for genetic disorders?
Magnetic muon measurements and gene-therapy advances win US$3 million Breakthrough prizes
